{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:14:09Z","timestamp":1781835249183,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":8102,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1023\/a:1008260817878","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T13:47:34Z","timestamp":1040564854000},"page":"1157-1158","source":"Crossref","is-referenced-by-count":9,"title":["Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma"],"prefix":"10.1016","volume":"8","author":[{"given":"L.","family":"Licitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Capri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fulfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tarenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008260817878_bb0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM198301133080204","article-title":"Chemotherapy in head and neck cancer","volume":"308","author":"Hong","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008260817878_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.annonc.a010467","article-title":"Chemotherapy for squamous cell carcinoma of head and neck: The future is now","volume":"7","author":"Vokes","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008260817878_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","article-title":"A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck","volume":"10","author":"Jacobs","year":"1992","journal-title":"J Clin Oncol"},{"issue":"Suppl 8","key":"10.1023\/A:1008260817878_bb0025","first-page":"49","article-title":"Paclitaxel (taxol) for the treatment of head and neck cancer","volume":"21","author":"Forastiere","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008260817878_bb0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Drug Therapy: Paclitaxel (Taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"10.1023\/A:1008260817878_bb0035","first-page":"109","article-title":"Biweekly paclitaxel and cisplatin: A phase I\/II study in the first-line treatment of metastatic breast cancer","volume":"22","author":"O\u2019Reilly","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008260817878_bb0040","first-page":"311","article-title":"Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials","volume":"21","author":"Browman","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008260817878_bb0045","first-page":"100","article-title":"Phase II trial of paclitaxel and cisplatin (DDP) in women with metastatic breast cancer","volume":"13","author":"Wasserheit","year":"1994","journal-title":"Am Soc Med Oncol"},{"key":"10.1023\/A:1008260817878_bb0050","first-page":"384a","article-title":"A phase III trial of high-dose paclitaxel + cisplatin + GCSF versus low-dose paclitaxel + cisplatin in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial","volume":"16","author":"Forastiere","year":"1997","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419640317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419640317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/11\/1157\/19480325\/8-11-1157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:12:42Z","timestamp":1582251162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419640317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["S0923753419640317"],"URL":"https:\/\/doi.org\/10.1023\/a:1008260817878","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}